The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...
Sarasota’s marine life faces immediate, lethal and other consequences from plastic. We need a better approach to how we use ...
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...
The Big Apple is about to be bled dry — and not just because of ferocious tax hikes. This spring and summer, NYC could see an ...
Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a major global health threat that acts as the primary vector for several severe ...
Zilliz, the creator of Milvus — the world's most widely adopted open-source vector database with over 43,000 GitHub stars and ...
FormFactor, Inc, a provider of radio frequency (RF) probe stations and probe cards, and Rohde & Schwarz, a global leader in ...
Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...
Combat-proven ISR platform will inform future Medium Range Reconnaissance (MRR) program MOORPARK, Calif., April 15, 2026 /PRNewswire/ -- Quantum-Systems Inc., a leader in unmanned intelligence and ...
Hyderabad:GHMC commissioner R.V. Karnan called for a scientific, citizen-focused and technology-driven approach to tackle mosquito-related problems. He was speaking at a GHMC event where officials ...
PARIS, France – 14 November 2025: Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ligand-conjugated vectors, today announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results